{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:53:08Z","timestamp":1793656388443,"version":"4.5.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ejmech.2024.117132","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T17:04:53Z","timestamp":1733245493000},"page":"117132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Structure-activity relationship study of novel evodiamine amino acid conjugates with potent anti-colorectal cancer efficacy"],"prefix":"10.1016","volume":"283","author":[{"given":"Shuting","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxuan","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuzhen","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxia","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linsheng","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengwen","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4134-1779","authenticated-orcid":false,"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zecheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.117132_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2024.117132_bib2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3892\/mco.2021.2433","article-title":"General insight into cancer: an overview of colorectal cancer","volume":"15","author":"Alzahrani","year":"2021","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2024.117132_bib3","first-page":"139268","article-title":"General aspects of colorectal cancer","volume":"2012","author":"Centelles","year":"2012","journal-title":"ISRN Oncol."},{"key":"10.1016\/j.ejmech.2024.117132_bib4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3322\/caac.21637","article-title":"Cancer statistics for adolescents and young adults, 2020","volume":"70","author":"Miller","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2024.117132_bib5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1272\/jnms.JNMS.2022_89-310","article-title":"Recent advances in the treatment of colorectal cancer: a review","volume":"3","author":"Shinji","year":"2022","journal-title":"J. Nippon Med. Sch."},{"key":"10.1016\/j.ejmech.2024.117132_bib6","first-page":"1","article-title":"Adjuvant therapy for completely resected stage II colon cancer","volume":"2008","author":"Figueredo","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejmech.2024.117132_bib7","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1056\/NEJMoa032709","article-title":"Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer","volume":"23","author":"Andr\u00e9","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2024.117132_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00003088-198916040-00002","article-title":"Clinical pharmacology of 5-fluorouracil","volume":"4","author":"Diasio","year":"1989","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejmech.2024.117132_bib9","doi-asserted-by":"crossref","first-page":"152882","DOI":"10.1016\/j.tox.2021.152882","article-title":"Oxaliplatin-induced hepatic sinusoidal obstruction syndrome","volume":"460","author":"Zhu","year":"2021","journal-title":"Toxicology"},{"key":"10.1016\/j.ejmech.2024.117132_bib10","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00280-016-2976-z","article-title":"Platinum-based drugs: past, present and future","volume":"77","author":"Dilruba","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.117132_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315410","article-title":"Revisiting the anti-cancer toxicity of clinically approved platinating derivatives","volume":"23","author":"Forgie","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.117132_bib12","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0306-3623(98)00191-8","article-title":"Resistance to 5-fluorouracil","volume":"31","author":"Mader","year":"1998","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.117132_bib13","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3816\/CCC.2009.n.034","article-title":"Is levoleucovorin an alternative to racemic leucovorin? A literature review","volume":"8","author":"Kovoor","year":"2009","journal-title":"Clin. Colorectal Cancer"},{"key":"10.1016\/j.ejmech.2024.117132_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110170","article-title":"Colon cancer and colorectal cancer: prevention and treatment by potential natural products","volume":"368","author":"Islam","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2024.117132_bib15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.soc.2017.11.001","article-title":"Systemic therapy for colon cancer","volume":"27","author":"Wu","year":"2018","journal-title":"Surg. Oncol. Clin."},{"key":"10.1016\/j.ejmech.2024.117132_bib16","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1002\/ptr.7099","article-title":"Natural products: a lead for drug discovery and development","volume":"35","author":"Chopra","year":"2021","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejmech.2024.117132_bib17","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.2174\/1389557522666220404090835","article-title":"Evodiamine: a privileged structure with broad-ranging biological activities","volume":"22","author":"Li","year":"2022","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117132_bib18","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/jphp.13238","article-title":"Evodiamine attenuates adjuvant-induced arthritis in rats by inhibiting synovial inflammation and restoring the Th17\/Treg balance","volume":"72","author":"Zhang","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.117132_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.899108","article-title":"The protective effect of evodiamine in osteoarthritis: an in vitro and in vivo study in mice model","volume":"13","author":"Xian","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.117132_bib20","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3892\/etm.2021.10762","article-title":"Research progress on evodiamine, a bioactive alkaloid of Evodiae fructus: focus on its anti-cancer activity and bioavailability","volume":"22","author":"Luo","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejmech.2024.117132_bib21","first-page":"1","article-title":"Evodiamine and its nano\u2010based approaches for enhanced cancer therapy: recent advances and challenges","author":"Solanki","year":"2024","journal-title":"J. Sci. Food Agric."},{"key":"10.1016\/j.ejmech.2024.117132_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10565-022-09772-8","article-title":"Evodiamine as an anticancer agent: a comprehensive review on its therapeutic application, pharmacokinetic, toxicity, and metabolism in various cancers","volume":"39","author":"Panda","year":"2022","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.ejmech.2024.117132_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176007","article-title":"Evodiamine impairs HIF1A histone lactylation to inhibit Sema3A-mediated angiogenesis and PD-L1 by inducing ferroptosis in prostate cancer","volume":"957","author":"Yu","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.117132_bib24","first-page":"27","article-title":"Topoisomerase I inhibitor evodiamine acts as an antibacterial agent against drug-resistant Klebsiella pneumoniae","volume":"79","author":"Wu","year":"2013","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2024.117132_bib25","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1016\/j.febslet.2009.10.046","article-title":"Evodiamine inhibits adipogenesis via the EGFR\u2013PKC\u03b1\u2013ERK signaling pathway","volume":"583","author":"Wang","year":"2009","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2024.117132_bib26","doi-asserted-by":"crossref","DOI":"10.1177\/1744806920902563","article-title":"Evodiamine reduced peripheral hypersensitivity on the mouse with nerve injury or inflammation","volume":"16","author":"Zhang","year":"2020","journal-title":"Mol. Pain"},{"key":"10.1016\/j.ejmech.2024.117132_bib27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11571-017-9471-z","article-title":"Protective effects of evodiamine in experimental paradigm of Alzheimer's disease","volume":"12","author":"Wang","year":"2018","journal-title":"Cogn. Neurodyn."},{"key":"10.1016\/j.ejmech.2024.117132_bib28","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1248\/bpb.24.917","article-title":"Inhibitory effects of evodiamine on in vitro invasion and experimental lung metastasis of murine colon cancer cells","volume":"24","author":"Ogasawara","year":"2001","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2024.117132_bib29","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.3390\/molecules14051852","article-title":"Evodiamine: a novel anti-cancer alkaloid from Evodia rutaecarpa","volume":"14","author":"Jiang","year":"2009","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.117132_bib30","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1053\/hupa.2002.129202","article-title":"Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases","volume":"33","author":"Boonsong","year":"2002","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ejmech.2024.117132_bib31","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1007\/s00595-011-4546-7","article-title":"Topoisomerase I expression in tumors as a biological marker for CPT-11 chemosensitivity in patients with colorectal cancer","volume":"41","author":"Ikeguchi","year":"2011","journal-title":"Surg. Today"},{"key":"10.1016\/j.ejmech.2024.117132_bib32","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1039\/C9CC00434C","article-title":"A concise synthesis and biological study of evodiamine and its analogues","volume":"55","author":"Deng","year":"2019","journal-title":"Chem. Commun. (Camb)"},{"key":"10.1016\/j.ejmech.2024.117132_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105981","article-title":"Discovery of evodiamine derivatives as potential lead antifungal agents for the treatment of superficial fungal infections","volume":"127","author":"Liang","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.117132_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113960","article-title":"Design, synthesis and bioactivity evaluation of novel evodiamine derivatives with excellent potency against gastric cancer","volume":"228","author":"Liang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117132_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116595","article-title":"Design, synthesis and bioactivity evaluation of novel N-phenyl-substituted evodiamine derivatives as potent anti-tumor agents","volume":"55","author":"Hao","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117132_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105154","article-title":"Design, synthesis and bioactivity study of evodiamine derivatives as multifunctional agents for the treatment of hepatocellular carcinoma","volume":"114","author":"Fan","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.117132_bib37","doi-asserted-by":"crossref","first-page":"7975","DOI":"10.1021\/acs.jmedchem.2c00520","article-title":"Design, synthesis, and biological evaluation of novel evodiamine derivatives as potential antihepatocellular carcinoma agents","volume":"65","author":"Lei","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117132_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114530","article-title":"Design, synthesis and bioactivity evaluation of favorable evodiamine derivative scaffold for developing cancer therapy","volume":"239","author":"Liang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117132_bib39","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.addr.2012.10.001","article-title":"Amino acids as promoieties in prodrug design and development","volume":"65","author":"Vig","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2024.117132_bib40","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.3390\/molecules23092318","article-title":"Amino acids in the development of prodrugs","volume":"23","author":"Vale","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.117132_bib41","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.2174\/1568026621666210602154438","article-title":"Amino acid derived prodrugs: an approach to improve the bioavailability of clinically approved drugs","volume":"21","author":"Singh","year":"2021","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117132_bib42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2174\/1389557519666191009152007","article-title":"Quercetin-amino acid conjugates are promising anti-cancer agents in drug discovery projects","volume":"20","author":"Dobrydnev","year":"2020","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117132_bib43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1021\/acschembio.7b00854","article-title":"Chemical proteomics reveals soluble epoxide hydrolase as a therapeutic target for ocular neovascularization","volume":"13","author":"Sulaiman","year":"2017","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.117132_bib44","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.bmcl.2016.01.082","article-title":"Antibacterial and antifungal activities of 2,3-pyrrolidinedione derivatives against oral pathogens","volume":"26","author":"Dhavan","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.117132_bib45","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/cmdc.201100504","article-title":"Dipeptidyl peptidase IV (DPPIV\/CD26)\u2010Based prodrugs of hydroxy-containing drugs","volume":"7","author":"Diez-Torrubia","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2024.117132_bib46","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.3390\/molecules27134040","article-title":"Design, synthesis, and biological evaluation of N14-amino acid-substituted tetrandrine derivatives as potential antitumor agents against human colorectal cancer","volume":"27","author":"Wang","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.117132_bib47","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1016\/j.bmcl.2013.02.048","article-title":"Synthesis and biological activity of 4-substituted benzoxazolone derivatives as a new class of sEH inhibitors with high anti-inflammatory activity in vivo","volume":"23","author":"Tang","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.117132_bib48","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1021\/acs.jmedchem.5b00449","article-title":"Synthesis and biological evaluation of novel homoisoflavonoids for retinal neovascularization","volume":"58","author":"Basavarajappa","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117132_bib49","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/cbdd.12507","article-title":"Synthesis and evaluation of millepachine amino acid prodrugs with enhanced solubility as antitumor agents","volume":"86","author":"Wu","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2024.117132_bib50","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.3390\/molecules24203647","article-title":"Synthesis of novel baicalein amino acid derivatives and biological evaluation as neuroprotective agents","volume":"24","author":"Jia","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.117132_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112293","article-title":"Synthesis, pharmacological profile and 2D-QSAR studies of curcumin-amino acid conjugates as potential drug candidates","volume":"196","author":"Panda","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117132_bib52","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/cbdd.13786","article-title":"Hepatoprotective activity assessment of amino acids derivatives of picroside I and II","volume":"97","author":"Dong","year":"2021","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2024.117132_bib53","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.3390\/sym13122277","article-title":"Chirality and the origin of life","volume":"13","author":"Dev\u00ednsky","year":"2021","journal-title":"Symmetry"},{"key":"10.1016\/j.ejmech.2024.117132_bib54","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0960-9822(00)00171-8","article-title":"Origin of life. The origin of macromolecular chirality","volume":"4","author":"Schwartz","year":"1994","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ejmech.2024.117132_bib55","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1039\/c000408c","article-title":"Pharmacologically active compounds in the environment and their chirality","volume":"39","author":"Kasprzyk-Hordern","year":"2010","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2024.117132_bib56","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1016\/j.bmc.2013.09.030","article-title":"Quinazolinecarboline alkaloid evodiamine as scaffold for targeting topoisomerase I and sirtuins","volume":"21","author":"Christodoulou","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117132_bib57","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1016\/S0957-4166(98)00415-7","article-title":"Enantioselective addition of diethylzinc to aldehydes induced by a new chiral Ti(IV) catalyst","volume":"9","author":"Hwang","year":"1998","journal-title":"Tetrahedron Asymmetry"},{"key":"10.1016\/j.ejmech.2024.117132_bib58","unstructured":"Full Crystallographic Details Has Been Deposited at the Cambridge Crystallographic Data Center and Allocated the Deposition Number CCDC 2006245 ((\u2212)-15h). in.https:\/\/www.ccdc.cam.ac.uk."},{"key":"10.1016\/j.ejmech.2024.117132_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115031","article-title":"Natural product evodiamine-inspired medicinal chemistry: anticancer activity, structural optimization and structure-activity relationship","volume":"247","author":"Wang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117132_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115366","article-title":"N(14)-substituted evodiamine derivatives as dual topoisomerase 1\/tubulin-Inhibiting anti-gastrointestinal tumor agents","volume":"255","author":"Deng","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117132_bib61","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S1359-6446(05)03675-5","article-title":"Druggability: selecting optimized drug candidates","volume":"10","author":"Sugiyama","year":"2005","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2024.117132_bib62","doi-asserted-by":"crossref","first-page":"7521","DOI":"10.1021\/jm100387d","article-title":"Selection of evodiamine as a novel topoisomerase I inhibitor by structure-based virtual screening and hit optimization of evodiamine derivatives as antitumor agents","volume":"53","author":"Dong","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117132_bib63","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1749-6632.1996.tb26395.x","article-title":"Topoisomerase-I inhibitors in the management of colon cancer","volume":"803","author":"Willson","year":"1996","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejmech.2024.117132_bib64","article-title":"Evodiamine induces G2\/M arrest and apoptosis via mitochondrial and endoplasmic reticulum pathways in H446 and H1688 human small-cell lung cancer cells","volume":"9","author":"Lebedeva","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2024.117132_bib65","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3390\/ijms23031328","article-title":"The apoptosis paradox in cancer","volume":"23","author":"Morana","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.117132_bib66","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jep.2016.04.050","article-title":"Isoorientin from Gypsophila elegans induces apoptosis in liver cancer cells via mitochondrial-mediated pathway","volume":"187","author":"Lin","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2024.117132_bib67","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/sj.onc.1210220","article-title":"The Bcl-2 apoptotic switch in cancer development and therapy","volume":"26","author":"Adams","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2024.117132_bib68","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.redox.2017.01.013","article-title":"Mitochondrial dynamics in type 2 diabetes: pathophysiological implications","volume":"11","author":"Rovira-Llopisa","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejmech.2024.117132_bib69","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1021\/jm049146p","article-title":"Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex","volume":"48","author":"Staker","year":"2005","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424010146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424010146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T18:59:28Z","timestamp":1741287568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424010146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":69,"alternative-id":["S0223523424010146"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117132","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-activity relationship study of novel evodiamine amino acid conjugates with potent anti-colorectal cancer efficacy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117132","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117132"}}